News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Views of NZ self-medication body at odds with safety

25 March 2014

Views of New Zealand self-medication body at odds with safety concerns of some members

AFT Pharmaceuticals (AFT) has identified a major error with the formulation of over 1300 cold and flu products used around the world.

Many over-the-counter (OTC) cold and flu products combine phenylephrine and paracetamol. AFT’s groundbreaking research has revealed that when paracetamol is combined with phenylephrine, the level of phenylephrine is effectively twice what it should be (20mg rather than the standard 10mg level that regulators allow).

The research was recently published in the prestigious New England Journal of Medicine. The discovery has received international attention, including in New Zealand, Australia, China, and the United States.

However, the reaction from the New Zealand Self-Medication Industry Association (NZSMI) has been disappointing. NZSMI acts as the local advocacy body for a number of multinational pharmaceutical companies with OTC operations in New Zealand.

Tim Roper, Executive Director at NZSMI, has been very quick to downplay the discovery. He reportedly told TVNZ that the New England Journal of Medicine publication lacked detail. He also implicitly criticised the integrity of the research because AFT has developed a drug that meets the permitted levels of phenylephrine. Thus, he is reported as saying that “the research done indicated a problem with competitive products but not with the ones that are about to be launched by the company that's involved”.

“These comments are nonsensical in our view,” says Dr Hartley Atkinson, Managing Director of AFT. “The research that underpins the discovery is of the highest standard. If it were anything less, the world’s premier medical journal would not publish it. Furthermore, these results were not from a ‘one off’ experiment. The same results were shown across, not one, but three separate clinical studies. The findings from all of the studies have been made available to the regulators and the additional studies submitted in a major article for publication in medical journals.”

“In addition, any possible implication from the NZSMI that the results may be comprised in some way because AFT has developed the correct formulation of an OTC product also make no sense,” said Dr Atkinson. “First, the New England Journal of Medicine simply would not publish the results if it considered they were tainted by commercial gain. Second, AFT would be failing consumers in New Zealand and around the world if it did not attempt to provide a product that actually delivers the functional 10mg dose of phenylephrine set by the regulators. Consumer safety must always be a cornerstone in the design of any pharmaceutical product, and we stand firmly in that camp.”

Ironically many of the multinational pharmaceutical companies that NZSMI represents argued against increasing the level of phenylephrine above 10mg in their submissions to the US Food and Drug Administration in 20071. The comprehensive 72 page report concluded that “oral phenylephrine 10mg is safe and effective as a nasal decongestant for over-the-counter use in adults” but that “there are insufficient data in adults to support the assertion that increasing the dose of phenylephrine to 25mg is necessary to produce clinically meaningful improvements in nasal decongestion with a similar safety profile as the currently available 10mg OTC monograph dose”.

Dr Atkinson adds, “Here is a discovery that shows combining phenylephrine with paracetamol effectively doubles the amount of phenylephrine in a person’s system – precisely the outcome these multinational pharmaceutical companies did not want, as stated in their submissions to the US Food and Drug Administration. Yet the response of the industry body in New Zealand is to raise doubts about AFT’s on-point research”.

The discovery raises important questions around the safe interaction of phenylephrine with paracetamol. It also raises further questions about the safe interaction between phenylephrine and other ingredients which have not been studied by AFT. For example, ascorbic acid (Vitamin C), which is used in some paracetamol and phenylephrine-based cold and flu remedies, can be expected to further increase the interaction between phenylephrine with paracetamol because of the way such ingredients are metabolized.

“Given the consumer safety imperative, NZSMI should be supportive of all efforts to broaden the knowledge base around possible interactions between phenylephrine and other substances. However, based on Tim Roper’s public comments, it appears this is not the position of NZSMI. I think the general public will be disappointed in this attitude. They will see the Association as ducking for cover on this important issue,” said Dr Atkinson.

ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Sheep: Shearing Record Smashed In Hawke’s Bay

Three shearers gathered from around New Zealand have smashed a World record by 264 sheep despite the heat, the pumiced sheep of inland Hawke’s Bay and a year’s wool weighing an average of over 3.5kg a sheep. More>>

ALSO:

Carrie Fisher: Hollywood In-Breeding & The Velocity Of Being - Binoy Kampmark

There was always going to be a good deal of thick drama around Carrie Fisher, by her own confession, a product of Hollywood in-breeding. Her parents, Debbie Reynolds and the crooner Eddie Fisher, provided ample material for the gossip columns in a marriage breakup after Eddie sped away with Elizabeth Taylor. More>>

  • Image: Tracey Nearmy / EPA
  • Gordon Campbell: On The Best Albums Of 2016

    OK, I’m not even going to try and rationalise this surrender to a ‘best of’ listicle. Still…maybe there is an argument for making some semblance of narrative order out of a year that brought us Trump, Brexit and the deaths of Prince, David Bowie, Leonard Cohen and Alan Vega, who I missed just as much as the Big Three. So without further ado….oh, but first a word from the sponsor More>>

    Emojis: World’s First Māori Emoji App Launched

    It’s here - the world’s first Māori emoji app Emotiki has landed just in time for summer roadtrips and santa stockings, with 200 Māori and Kiwi cultural icons for people to share their kiwiana moments with each other and the world. More>>

    ALSO:

    Howard Davis: Album Of The Year - Van Morrison's 'Keep Me Singing'

    2016 was a grand year for Van The Man - The Belfast Cowboy turned 71, received a knighthood, and reissued an expanded set of soul-fired live recordings from 1973 ('It's Too Late to Stop Now'). In the game for 53 years now, Morrison's albums consistently open new windows into the heart and soul of one of the most enigmatic figures in modern music. More>>

    Review: The NZSO Performs Handel's Messiah

    Max Rashbrooke: Saturday night's performance took the piece back to something like the way it would have originally been performed when premiered in 1742, with an orchestra of 20-30 players and only a few more singers. More>>

    Culture: Rare Hundertwasser Conservation Posters Found After 40 Years

    When Jan and Arnold Heine put a roll of conservation posters into storage in 1974 they had no idea that 42 years later they would be collectors items. More>>

    Get More From Scoop

     
     

    LATEST HEADLINES

     
     
     
     
    Health
    Search Scoop  
     
     
    Powered by Vodafone
    NZ independent news